As the Trump administration erodes U.S. infrastructure supporting infectious disease vaccines, mRNA heavyweight Moderna plans ...
In 2025's third quarter, multiple large vaccine developers, including Pfizer and GSK, saw vaccine sales tick up globally ...
Asianet Newsable on MSN
MRNA VS NVAX: Which vaccine stock is Wall Street more bullish on right now?
Regulatory uncertainty remains a common factor for both companies following an FDA memo that raised concerns about vaccine ...
The University of Auckland is hosting the research as part of the Global COVID Vaccine Safety (GCoVS) Project. Scientists ...
Bayer going after Pfizer for patent infringement is a forerunner for widespread abuse of intellectual property claims in food ...
The unprecedented changes have led to diminished vaccine usage, and created a drag that will likely dent revenues.
WASHINGTON — The most widely used COVID-19 vaccines may offer a surprise benefit for some cancer patients — revving up their immune systems to help fight tumors. People with advanced lung or skin ...
Top pharma stocks by Quant Ratings: see Strong Buy/Buy picks across PJP/XPH/PPH—plus why Moderna surged on new cancer-trial ...
The Oregon Legislature attempted to pass a bill to eliminate nonmedical vaccine exemptions in 2019 and was met with heavy resistance from parents and advocates citing medical freedom. Five years later ...
The Trump administration has rolled back decades-old guidance recommending routine childhood vaccination against influenza and three other infectious diseases, saying their use should instead be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results